Workflow
Unisplendour Corporation Limited(H0192) - Application Proof (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Unisplendour Corporation Limited 紫光股份有限公司 (the "Company") (A joint stock limited company incorporated in the People ...
WUS Printed Circuit (Kunshan) Co., Ltd.(H0191) - OC Announcement - Appointment (Revised)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. WUS PRINTED CIRCUIT (KUNSHAN) CO., LTD. 滬士電子股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) W ...
Unisplendour Corporation Limited(H0192) - OC Announcement - Appointment
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Unisplendour Corporation Limited 紫光股份有限公司 No offer or invitation will be made to the public in Hong Kong until after a prospectus of the Company h ...
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. - B(03378) - PHIP (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (翰思艾泰生物醫藥科技 (武 漢 )股份有限公司 ) (the "Comp ...
Shenzhen CVA Innovation Co., Ltd.(H0193) - Application Proof (1st submission)
2025-12-02 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of SHENZHEN CVA INNOVATION CO., LTD.* 深圳曦華科技股份有限公司 (A joint stock company incorporated in the People's Republic of Chi ...
Shenzhen CVA Innovation Co., Ltd.(H0193) - OC Announcement - Appointment
2025-12-02 16:00
SHENZHEN CVA INNOVATION CO., LTD.* 深圳曦華科技股份有限公司 (A joint stock company incorporated in the People's Republic of China with limited liability) WARNING The publication of this announcement is required by The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Securities and Futures Commission (the "Commission") solely for the purpose of providing information to the public in Hong Kong. By viewing this announcement, you acknowledge, accept and agree with Shenzhen CVA Innovation Co., Ltd.* (深圳曦華科 ...
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. - B(03378) - Application Proof (1st submission)
2025-12-02 16:00
WARNING The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (翰思艾泰生物醫藥科技(武漢)股份有限公司 ) (the "Company") (A joint stock company in ...
Shenzhen SDMC Technology Co., Ltd.(H0183) - Application Proof (1st submission)
2025-12-01 16:00
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this application proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this application proof. Application Proof of Shenzhen SDMC Technology Co., Ltd. 深圳市華曦達科技股份有限公司 (the "Company") (a joint stock company incorporated in the People ...
Anker Innovations Technology Co., Ltd.(H0188) - OC Announcement - Appointment
2025-12-01 16:00
(a) the publication of this announcement on the Stock Exchange's website does not give rise to any obligation of the Company, its joint sponsors, overall coordinators, advisors or members of the underwriting syndicate to proceed with an offering or a placing in Hong Kong or any other jurisdiction. There is no assurance that the Company will proceed with the offering or the placing; (b) the application to which this announcement relates has not been approved for listing and the Stock Exchange and the Commiss ...
Pharmeyes Cayman Holding Limited(H0185) - Application Proof (1st submission)
2025-12-01 16:00
Application Proof of The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. If an offer or an invitation is made to the public in Hong Kong in due course, prospective investors are reminded t ...